v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Cash flows from operating activities:    
Net income $ 254,603 $ 216,308
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 201,569 229,425
Amortization of deferred contract acquisition costs 69,557 68,125
Depreciation and amortization 35,316 26,667
Deferred income taxes (24,690) (7,952)
Losses (gains) on strategic investments, net 13,619 (17,354)
Provision for accounts receivable allowances 5,855 6,782
Unrealized foreign exchange (gains) losses (7,626) 7,237
Non-cash operating lease cost 6,108 5,368
Amortization of discount/premium on marketable securities (12,845) (17,668)
Other 4,142 98
Changes in operating assets and liabilities:    
Accounts receivable 12,485 12,260
Prepaid expenses and other assets (12,293) 35,839
Deferred contract acquisition costs (48,148) (40,128)
Accounts payable 7,252 7,276
Accrued expenses and other liabilities (80,383) (14,942)
Deferred revenue 72,141 77,964
Operating lease liabilities, net (7,401) (7,114)
Net cash provided by operating activities 489,261 588,191
Cash flows from investing activities:    
Purchases of marketable securities (1,135,024) (867,911)
Maturities of marketable securities 1,033,279 776,941
Sales of marketable securities 2,525 0
Purchases of property and equipment (25,910) (18,508)
Purchases of strategic investments 0 (3,000)
Proceeds from strategic investments 0 4,654
Net cash used in investing activities (125,130) (107,824)
Cash flows from financing activities:    
Proceeds from exercise of stock options 954 1,016
Proceeds from employee equity transactions to be remitted to employees and tax authorities, net 8,690 6,581
Cash paid for repurchases of common stock (418,021) (150,048)
Taxes paid related to net share settlement of equity awards (82,153) 0
Net cash used in financing activities (490,530) (142,451)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 11,854 (6,852)
Net (decrease) increase in cash, cash equivalents, and restricted cash (114,545) 331,064
Cash, cash equivalents, and restricted cash – beginning of period 1,361,417 1,565,380
Cash, cash equivalents, and restricted cash – end of period 1,246,872 1,896,444
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:    
Cash and cash equivalents 1,228,847 1,885,603
Restricted cash, current included in prepaid expenses and other current assets 18,025 10,588
Restricted cash, noncurrent included in other assets, noncurrent 0 253
Total cash, cash equivalents, and restricted cash $ 1,246,872 $ 1,896,444